Lataa...
25 Years of Contrast-Enhanced MRI: Developments, Current Challenges and Future Perspectives
ABSTRACT: In 1988, the first contrast agent specifically designed for magnetic resonance imaging (MRI), gadopentetate dimeglumine (Magnevist(®)), became available for clinical use. Since then, a plethora of studies have investigated the potential of MRI contrast agents for diagnostic imaging across...
Tallennettuna:
| Julkaisussa: | Adv Ther |
|---|---|
| Päätekijät: | , , , , , , , , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Springer Healthcare
2016
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4735235/ https://ncbi.nlm.nih.gov/pubmed/26809251 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12325-015-0275-4 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|